Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs

The Journal of Infectious Diseases
Susan T GoldsteinHarold S Margolis

Abstract

From 1982-1998, enhanced sentinel surveillance for acute hepatitis B was conducted in 4 counties in the United States to determine trends in disease incidence and risk factors for infection. During this period, the reported incidence of acute hepatitis B declined by 76.1% from 13.8 cases per 100,000 in 1987 to 3.3 cases per 100,000 in 1998. Cases associated with injection drug use (IDU) decreased by 90.6%, men who have sex with men (MSM) by 63.5%, and heterosexual activity by 50.7%. During 1994-1998, the most commonly reported risk factor for infection was high-risk heterosexual activity (39.8%) followed by MSM activity (14.6%) and IDU (13.8%). Over half of all patients (55.5%) reported treatment for a sexually transmitted disease (STD) or incarceration in a prison or jail prior to their illness, suggesting that more than half of the acute hepatitis B cases might have been prevented through routine hepatitis B immunization in STD clinics and correctional health care programs.

Citations

Feb 3, 2009·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Shaili Gupta, Frederick L Altice
Nov 1, 2002·Current Treatment Options in Gastroenterology·Raymond S. Koff
May 17, 2005·American Journal of Preventive Medicine·UNKNOWN Task Force on Community Preventive Services
May 17, 2005·American Journal of Preventive Medicine·Serigne M NdiayeUNKNOWN Task Force on Community Preventive Services
Jun 17, 2005·American Journal of Preventive Medicine·Robert A GunnHarold S Margolis
Apr 20, 2004·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·R Jake Jacobs, Allen S Meyerhoff
Jun 15, 2004·Preventive Medicine·Snigdha VallabhaneniJosiah D Rich
Apr 12, 2003·The American Journal of Medicine·Josiah D RichTimothy P Flanigan
Feb 21, 2004·Lancet·Basil Donovan
Sep 10, 2003·The Journal of Infection·I E GjørupA-M Plesner
Sep 10, 2002·Journal of Hepatology·Jim E van Steenbergen, UNKNOWN Working Group Vaccination High-risk Groups Hepatitis B for the Netherlands
Jan 8, 2004·Journal of Hepatology·Miriam J Alter
Jan 8, 2004·Journal of Hepatology·Michael Roggendorf, Sergei Viazov
Aug 19, 2003·Vaccine·Bernd WoltersMichael Roggendorf
Apr 17, 2008·Nature Clinical Practice. Gastroenterology & Hepatology·Evelyn K Hsu, Karen F Murray
Sep 27, 2003·Journal of American College Health : J of ACH·R Jake JacobsAllen S Meyerhoff
Feb 7, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Irene KuoSusan G Sherman
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ellen M TedaldiUNKNOWN HIV Outpatient Study (HOPS) Investigators
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·I T WilliamsB P Bell
Sep 6, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Grace E MacalinoJosiah D Rich
Feb 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fatma A MekyG Thomas Strickland
Jan 6, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen M ChunUNKNOWN Infectious Disease Clinical Research Program HIV Working Group
Oct 13, 2010·The Journal of Infectious Diseases·Lu-Yu HwangMark Williams
Aug 24, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eyasu H TeshaleYuri Khudyakov
Mar 5, 2005·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Frederick L AlticeMarta I Buitrago
Aug 15, 2003·Sexually Transmitted Diseases·Catherine DiamondUNKNOWN Seattle Young Men's Survey Team
Sep 9, 2005·The Pediatric Infectious Disease Journal·Catherine M DentingerAlan J Parkinson
Sep 16, 2003·Sexually Transmitted Diseases·Stephanie SansomWendy Douglas
Dec 3, 2003·Sexually Transmitted Diseases·Mary Jo TrepkaToye Brewer
Aug 17, 2011·Sexually Transmitted Diseases·James SosmanUNKNOWN Project START Biologics Study Group
Feb 14, 2013·Sexually Transmitted Diseases·Catherine Lindsey SatterwhiteHillard Weinstock
Jun 3, 2009·AIDS·Michael L LandrumUNKNOWN Infectious Disease Clinical Research Program HIV Working Group
May 27, 2006·Journal of Gastroenterology and Hepatology·Juan A del OlmoJosé M Rodrigo
Apr 25, 2013·PloS One·Sofiane MohamedPhilippe Halfon
Feb 21, 2009·World Journal of Gastroenterology : WJG·Bashkim ResuliEdita Sadiku

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.